Logo image of MTBCP

CARECLOUD INC - MTBC 11 PERP (MTBCP) Stock Fundamental Analysis

NASDAQ:MTBCP - Nasdaq - US14167R2094 - Currency: USD

26.9137  -0.08 (-0.28%)

Fundamental Rating

3

Overall MTBCP gets a fundamental rating of 3 out of 10. We evaluated MTBCP against 37 industry peers in the Health Care Technology industry. While MTBCP seems to be doing ok healthwise, there are quite some concerns on its profitability. MTBCP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MTBCP has reported negative net income.
MTBCP had a positive operating cash flow in the past year.
MTBCP Yearly Net Income VS EBIT VS OCF VS FCFMTBCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 10M -10M -20M

1.2 Ratios

The profitability ratios for MTBCP are negative, so there is not much use analyzing them.
MTBCP's Return On Invested Capital of 4.81% is amongst the best of the industry. MTBCP outperforms 84.44% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 4.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTBCP Yearly ROA, ROE, ROICMTBCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

1.3 Margins

With a decent Operating Margin value of 3.77%, MTBCP is doing good in the industry, outperforming 73.33% of the companies in the same industry.
MTBCP has a Gross Margin of 38.04%. This is in the lower half of the industry: MTBCP underperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of MTBCP has declined.
Industry RankSector Rank
OM 3.77%
PM (TTM) N/A
GM 38.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
MTBCP Yearly Profit, Operating, Gross MarginsMTBCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTBCP is destroying value.
MTBCP has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MTBCP has a worse debt to assets ratio.
MTBCP Yearly Shares OutstandingMTBCP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M
MTBCP Yearly Total Debt VS Total AssetsMTBCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M

2.2 Solvency

An Altman-Z score of 9.66 indicates that MTBCP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.66, MTBCP belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
MTBCP has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
MTBCP has a Debt to FCF ratio of 0.06. This is amongst the best in the industry. MTBCP outperforms 82.22% of its industry peers.
MTBCP has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, MTBCP is in the better half of the industry, outperforming 64.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Altman-Z 9.66
ROIC/WACC0.6
WACC8.03%
MTBCP Yearly LT Debt VS Equity VS FCFMTBCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

MTBCP has a Current Ratio of 1.21. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.21, MTBCP is doing worse than 73.33% of the companies in the same industry.
MTBCP has a Quick Ratio of 1.19. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
MTBCP has a Quick ratio of 1.19. This is in the lower half of the industry: MTBCP underperforms 71.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.19
MTBCP Yearly Current Assets VS Current LiabilitesMTBCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

MTBCP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.73%, which is quite impressive.
MTBCP shows a small growth in Revenue. In the last year, the Revenue has grown by 7.14%.
MTBCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.63% yearly.
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%

3.2 Future

MTBCP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.25% yearly.
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MTBCP Yearly Revenue VS EstimatesMTBCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MTBCP Yearly EPS VS EstimatesMTBCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MTBCP. In the last year negative earnings were reported.
Also next year MTBCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTBCP Price Earnings VS Forward Price EarningsMTBCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

MTBCP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MTBCP is cheaper than 84.44% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MTBCP is valued a bit cheaper than 71.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.5
EV/EBITDA 23.41
MTBCP Per share dataMTBCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

MTBCP's earnings are expected to grow with 16.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.89%
EPS Next 3Y16.8%

More info and screens

0

5. Dividend

5.1 Amount

MTBCP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARECLOUD INC - MTBC 11 PERP

NASDAQ:MTBCP (1/9/2023, 8:23:58 PM)

26.9137

-0.08 (-0.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-03 2022-11-03/bmo
Earnings (Next)03-13 2023-03-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap409.63M
Analysts83.64
Price Target76.1 (182.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-220.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.24%
Min EPS beat(2)4.61%
Max EPS beat(2)61.87%
EPS beat(4)4
Avg EPS beat(4)48.06%
Min EPS beat(4)4.61%
Max EPS beat(4)94.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.43%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.85
P/FCF 46.5
P/OCF 19.3
P/B 3.98
P/tB 34.48
EV/EBITDA 23.41
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.58
FCFY2.15%
OCF(TTM)1.39
OCFY5.18%
SpS9.44
BVpS6.76
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 4.81%
ROICexc 4.99%
ROICexgc 43.34%
OM 3.77%
PM (TTM) N/A
GM 38.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Debt/EBITDA 0.03
Cap/Depr 103.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.19
Altman-Z 9.66
F-Score4
WACC8.03%
ROIC/WACC0.6
Cap/Depr(3y)81.08%
Cap/Depr(5y)58.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
EBIT growth 1Y261.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1308.1%
EBIT Next 3Y177.57%
EBIT Next 5Y93.09%
FCF growth 1Y213.67%
FCF growth 3Y-21.74%
FCF growth 5YN/A
OCF growth 1Y1553.9%
OCF growth 3Y25.1%
OCF growth 5YN/A